Conversely, DIO intervention markedly diminished the heightened expression of NLRP3 inflammasome elements in diabetic nephropathy, suggesting its robust anti-inflammatory effect by curbing NLRP3 inflammasome activation in living organisms. This evidence concerns the gene NLRP3 and diabetic kidney disease.